Qyuns Therapeutics Co., Ltd. (HKEX:2509) Filings

Qyuns Therapeutics Co., Ltd.

Filings

FilingDateTypeFiled with
SUPPLEMENTAL AGREEMENT TO THE CDMO SERVICES FRAMEWORK AGREEMENT AND REVISION OF ANNUAL CAP AND RENEWAL OF ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONSNov 13, 2026Material contractHKEX
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONSNov 13, 2026List of directorsHKEX
(1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON NOVEMBER 13, 2026&#x3b; (2) APPOINTMENT OF NON-EXECUTIVE DIRECTOR&#x3b; AND (3) CHANGE IN COMPOSITION OF BOARD COMMITTEENov 13, 2026Meeting outcomeHKEX
VOLUNTARY ANNOUNCEMENT EXCLUSIVE LICENSE AGREEMENT WITH CALDERA THERAPEUTICS FOR A PRECLINICAL BISPECIFIC ANTIBODY PROGRAM TARGETING TL1A AND IL-17Nov 5, 2026Other filingsHKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026Nov 5, 2026Monthly returnHKEX
Documents on DisplayOct 27, 2026Notification letterHKEX
Documents on DisplayOct 27, 2026Other filingsHKEX
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, NOVEMBER 13, 2026Oct 27, 2026Proxy formHKEX
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETINGOct 27, 2026Meeting noticeHKEX
(1) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE REVISION OF ANNUAL CAPS FOR THE QX001S FRAMEWORK AGREEMENT&#x3b; (2) PROPOSED APPOINTMENT OF DIRECTOR AND DETERMINATION OF THE DIRECTOR'S REMUNERATION&#x3b; AND (3) NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETINGOct 27, 2026Meeting noticeHKEX
ANNOUNCEMENT BOOK CLOSURE PERIOD FOR EXTRAORDINARY GENERAL MEETINGOct 26, 2026Meeting noticeHKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026Oct 7, 2026Monthly returnHKEX
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL STUDY RESULTS OF OTURKIBART (QX005N) FOR TREATMENT OF PRURIGO NODULARIS PRESENTED AS A LATE-BREAKING ORAL PRESENTATION AT EADV 2026Oct 1, 2026Other filingsHKEX
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONSSep 22, 2026List of directorsHKEX
CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE REVISION OF ANNUAL CAPS FOR THE QX001S FRAMEWORK AGREEMENT&#x3b; AND RESIGNATION AND PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTORSep 22, 2026Management or board changeHKEX
2026 INTERIM REPORTSep 21, 2026Interim reportHKEX